ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,948.71
      0.53%
      US Tech 100
      20,144.80
      0.09%
      Dow Jones
      43,870.35
      1.06%
      Brent Oil
      74.22
      0.39%
      Bitcoin
      98,699.77
      0.19%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Tourmaline Bio Inc (TRML) Quote

      Tourmaline Bio Inc

      Tourmaline Bio Inc (TRML)

      NASDAQ
      22.72
      -1.28
      (-5.33%)
      Closed November 21 4:00PM
      Delayed by 15 minutes
      22.72
      -0.02
      (-0.09%)
      After Hours: 6:55PM
      Delayed by 15 minutes

      Professional-Grade Tools, for Individual Investors.

      Premium

      Key stats and details

      Current Price
      22.72
      Bid
      21.00
      Ask
      26.00
      Volume
      188,865
      22.57 Day's Range 24.365
      12.12 52 Week Range 48.31
      Market Cap
      582.6M
      Previous Close
      24.00
      Open
      23.86
      Last Trade
      1
      @
      23.48
      Last Trade Time
      Financial Volume
      $ 4,390,938
      VWAP
      23.2491
      Average Volume (3m)
      231,032
      Shares Outstanding
      25,642,610
      Dividend Yield
      -
      PE Ratio
      -13.84
      Earnings Per Share (EPS)
      -1.64
      Revenue
      -
      Net Profit
      -42.12M

      About Tourmaline Bio Inc

      Talaris Therapeutics Inc is a late-clinical stage biotechnology company. It is developing transformative cell therapies with the potential to eliminate the burden of chronic immunosuppression for organ transplant recipients as well as induce durable remissions in patients with severe autoimmune and ... Talaris Therapeutics Inc is a late-clinical stage biotechnology company. It is developing transformative cell therapies with the potential to eliminate the burden of chronic immunosuppression for organ transplant recipients as well as induce durable remissions in patients with severe autoimmune and immune-mediated disorders. Show more

      Sector
      Biological Pds,ex Diagnstics
      Industry
      Biological Pds,ex Diagnstics
      Website
      talaristx.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      -
      Tourmaline Bio Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker TRML. The last closing price for Tourmaline Bio was $24. Over the last year, Tourmaline Bio shares have traded in a share price range of $ 12.12 to $ 48.31.

      Tourmaline Bio currently has 25,642,610 shares outstanding. The market capitalization of Tourmaline Bio is $615.42 million. Tourmaline Bio has a price to earnings ratio (PE ratio) of -13.84.

      Ask ADVFN Intelligence (AI)

      TRML Latest News

      More News

      Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

      November 14 2024
      Edgar (US Regulatory)

      Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

      November 14 2024
      Edgar (US Regulatory)

      Tourmaline Bio to Host Investor Day on Tuesday, December 10, 2024

      NEW YORK, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Tourmaline Bio, Inc. (Tourmaline) (NASDAQ: TRML), a late-stage clinical biotechnology company developing transformative medicines to dramatically...

      November 14 2024
      GlobeNewswire Inc.

      Form SC 13G - Statement of Beneficial Ownership by Certain Investors

      November 08 2024
      Edgar (US Regulatory)

      Form S-3 - Registration statement under Securities Act of 1933

      November 07 2024
      Edgar (US Regulatory)

      Form 10-Q - Quarterly report [Sections 13 or 15(d)]

      November 07 2024
      Edgar (US Regulatory)

      Form 8-K - Current report

      November 07 2024
      Edgar (US Regulatory)

      Tourmaline Bio Reports Third Quarter 2024 Financial Results and Recent Business Highlights

      – On track to report topline data from Phase 2 TRANQUILITY trial in first half of 2025 – – Assembled Cardiovascular Scientific Advisory Board (CV SAB), comprised of leading academic and industry...

      November 07 2024
      GlobeNewswire Inc.

      Tourmaline Bio to Present at Upcoming Investor Conferences

      NEW YORK, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Tourmaline Bio, Inc. (Tourmaline) (NASDAQ: TRML), a late-stage clinical biotechnology company developing transformative medicines to dramatically...

      October 31 2024
      GlobeNewswire Inc.

      Tourmaline Bio to Host Expert Webinar on Human Genetic Validation for IL-6 Inhibition in Cardiovascular Disease with Dr. Dipender Gill on Friday, November 1, 2024

      NEW YORK, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Tourmaline Bio, Inc. (Tourmaline) (NASDAQ: TRML), a late-stage clinical biotechnology company developing transformative medicines to dramatically...

      October 15 2024
      GlobeNewswire Inc.
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-3.85-14.490026345526.5727.5122.7221609224.79726844CS
      4-5.46-19.37544357728.1829.646122.7218210026.37427012CS
      124.8827.354260089717.8429.788315.235423103224.64364776CS
      268.2256.689655172414.529.788312.1222432219.38628493CS
      524.6225.524861878518.148.3112.1226952023.3131973CS
      15612.4120.1550387610.3248.319.1825360223.10524095CS
      26012.4120.1550387610.3248.319.1825360223.10524095CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      WORXSCWorx Corporation
      $ 2.12
      (116.33%)
      		144.38M
      CRNCCerence Inc
      $ 5.83
      (106.74%)
      		77.55M
      PROCProcaps Group SA
      $ 1.10
      (92.48%)
      		2.58M
      IBGInnovation Beverage Group Limited
      $ 1.19
      (50.40%)
      		12.97M
      ARQQArqit Quantum Inc
      $ 10.7599
      (46.59%)
      		900.38k
      SKKSKK Holdings Limited
      $ 1.01
      (-77.85%)
      		40.45M
      TMTCTMT Acquisition Corporation
      $ 2.20
      (-65.84%)
      		530.14k
      WCTWellchange Holdings Company Limited
      $ 1.2596
      (-62.06%)
      		2.34M
      TMTCUTMT Acquisition Corporation
      $ 2.89
      (-56.74%)
      		14.07k
      GLXGGalaxy Payroll Group Ltd
      $ 1.77
      (-54.73%)
      		2.45M
      CDTConduit Pharmaceuticals Inc
      $ 0.1048
      (13.54%)
      		579M
      NVDANVIDIA Corporation
      $ 146.67
      (0.53%)
      		401.66M
      ELABElevai Labs Inc
      $ 0.020072
      (-6.21%)
      		256.24M
      AKTSAkoustis Technologies Inc
      $ 0.1022
      (17.34%)
      		211.19M
      MARAMARA Holdings Inc
      $ 24.19
      (6.89%)
      		166.43M

      TRML Discussion

      View Posts
      Monksdream Monksdream 4 weeks ago
      TRML under $30
      👍️0
      Monksdream Monksdream 8 months ago
      TRML over $20
      👍️0

      Your Recent History

      NASDAQ
      TRML
      Tourmaline Bio
      Delayed Upgrade Clock